Correlation Between Hepion Pharmaceuticals and Absci Corp

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Hepion Pharmaceuticals and Absci Corp at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Hepion Pharmaceuticals and Absci Corp into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Hepion Pharmaceuticals and Absci Corp, you can compare the effects of market volatilities on Hepion Pharmaceuticals and Absci Corp and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Hepion Pharmaceuticals with a short position of Absci Corp. Check out your portfolio center. Please also check ongoing floating volatility patterns of Hepion Pharmaceuticals and Absci Corp.

Diversification Opportunities for Hepion Pharmaceuticals and Absci Corp

0.17
  Correlation Coefficient

Average diversification

The 3 months correlation between Hepion and Absci is 0.17. Overlapping area represents the amount of risk that can be diversified away by holding Hepion Pharmaceuticals and Absci Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Absci Corp and Hepion Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Hepion Pharmaceuticals are associated (or correlated) with Absci Corp. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Absci Corp has no effect on the direction of Hepion Pharmaceuticals i.e., Hepion Pharmaceuticals and Absci Corp go up and down completely randomly.

Pair Corralation between Hepion Pharmaceuticals and Absci Corp

Given the investment horizon of 90 days Hepion Pharmaceuticals is expected to generate 1.11 times more return on investment than Absci Corp. However, Hepion Pharmaceuticals is 1.11 times more volatile than Absci Corp. It trades about -0.02 of its potential returns per unit of risk. Absci Corp is currently generating about -0.08 per unit of risk. If you would invest  74.00  in Hepion Pharmaceuticals on August 31, 2024 and sell it today you would lose (10.00) from holding Hepion Pharmaceuticals or give up 13.51% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Hepion Pharmaceuticals  vs.  Absci Corp

 Performance 
       Timeline  
Hepion Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Hepion Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Hepion Pharmaceuticals is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.
Absci Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Absci Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.

Hepion Pharmaceuticals and Absci Corp Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Hepion Pharmaceuticals and Absci Corp

The main advantage of trading using opposite Hepion Pharmaceuticals and Absci Corp positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Hepion Pharmaceuticals position performs unexpectedly, Absci Corp can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Absci Corp will offset losses from the drop in Absci Corp's long position.
The idea behind Hepion Pharmaceuticals and Absci Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Bonds Directory
Find actively traded corporate debentures issued by US companies
CEOs Directory
Screen CEOs from public companies around the world